Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
J Clin Ethics ; 31(3): 259-267, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32960808

RESUMO

Organizational ethics programs often are created to address tensions in organizational values that have been identified through repeated clinical ethics consultation requests. Clinical ethicists possess some core competencies that are suitable for the leadership of high-quality organizational ethics programs, but they may need to develop new skills to build these programs, such as familiarity with healthcare delivery science, healthcare financing, and quality improvement methodology. To this end, we suggest that clinical ethicists build organizational ethics programs incrementally and via quality improvement projects undertaken in collaboration with senior clinical leaders. Organizational ethics programs often differ from clinical ethics programs in their membership and processes, and likely will require ethicists to forge new partnerships with a wide array of organizational leaders. With attention to the ways that organizational ethics programs differ from clinical ethics programs, and investment in quality improvement methodology and formal institutional needs assessments, clinical ethics leaders can position an organizational ethics program to advocate effectively for visible and compelling alignment of leadership decision making with the values of the organization.


Assuntos
Consultoria Ética , Ética Institucional , Eticistas , Ética Clínica , Humanos , Liderança
2.
HEC Forum ; 25(2): 111-26, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23553494

RESUMO

Catholic healthcare institutions live amidst tension between three intersecting primary values, namely, a commitment of service to the poor and vulnerable, promoting the common good for all, and financially sustainability. Within this tension, the question sometimes arises as to whether it is ever justifiable, i.e., consistent with Catholic identity, to place limits on charity care. In this article we will argue that the health reform measures of the Affordable Care Act do not eliminate this tension but actually increase the urgency of addressing it. Moreover, we will conclude that the question of limiting charity care in a manner that is consistent with the obligations of Catholic identity around serving the poor and vulnerable, promoting the common good, and remaining financially sustainable is not a question of if, but of how such limits are established. Such limits, however, cannot be established in light of one overriding moral consideration or principle, but must be established in light of a multitude of principles guiding us to a holistic understanding of the interrelatedness of the moral dimensions of Catholic identity.


Assuntos
Beneficência , Catolicismo , Hospitais Religiosos , Patient Protection and Affordable Care Act , Hospitais Religiosos/economia , Cuidados de Saúde não Remunerados , Estados Unidos
6.
Health Care Ethics USA ; 13(3): E1, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16604749

RESUMO

Genetic testing is becoming ever more prevalent in the post-genome project practice of medicine. Subsequently, genetic testing for disorders lacking any therapeutic interventions is also becoming more prevalent. This article will examine some of the ethical challenges raised by our ability to know but not to cure.


Assuntos
Testes Genéticos/ética , Aconselhamento Genético/ética , Doenças Genéticas Inatas/diagnóstico , Humanos , Consentimento Livre e Esclarecido/ética , Prognóstico
7.
Health Care Ethics USA ; 13(2): E2, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16273741

RESUMO

Ethics committees are use [sic] to questions concerning the withdrawal of life-support. Such questions become increasingly complex when that life-support is implantable, like a pacemaker. This essay seeks to address the question of under what, if any, circumstances it would be permissible to discontinue the use of such implantable devices.


Assuntos
Catolicismo , Desfibriladores Implantáveis , Marca-Passo Artificial , Suspensão de Tratamento/ética , Eutanásia Passiva , Homicídio , Humanos , Qualidade de Vida , Medição de Risco
9.
Health Prog ; 87(1): 68-72, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16519287
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA